Surplus Solutions Partners with FAMECO Group ApS to Expand Internationally
October 2, 2024
Surplus Solutions, a portfolio company of NMS Capital, has expanded internationally through a partnership (add-on acquisition) with FAMECO Group ApS, a Strasbourg-based seller and refurbisher of analytical laboratory and medical equipment. The deal provides Surplus Solutions with an established European footprint, refurbishment capabilities, and inventory to accelerate cross-border growth and build out technical service offerings.
- Buyers
- Surplus Solutions LLC, NMS Capital
- Targets
- FAMECO Group ApS
- Platforms
- Surplus Solutions LLC
- Industry
- Medical Devices
- Location
- Grand Est, France
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
NMS Capital Recapitalizes Surplus Solutions LLC
December 6, 2022
Healthcare Services
NMS Capital has partnered with Surplus Solutions’ management in a recapitalization of Surplus Solutions LLC; terms were not disclosed. The investment will support geographic and inventory expansion, strategic M&A, and investments in infrastructure and operations to drive the company's next phase of growth; Twin Brook Capital provided debt financing.
-
AMECO Acquires F&M MAFCO
May 4, 2022
Construction
AMECO, a site services platform and portfolio company of One Equity Partners, has acquired F&M MAFCO, an international supplier of tools and equipment rental, sales and service programs. The deal expands AMECO's site services capabilities and geographic reach, with F&M MAFCO maintaining a significant operations presence in Cincinnati and its CEO Tim Fries named chief growth officer of the combined organization.
-
Surplus Solutions (NMS Capital) Acquires Certified Genetool
April 7, 2025
Healthcare Services
Surplus Solutions LLC, an NMS Capital portfolio company, has acquired Certified Genetool, a San Francisco-based provider of certified and refurbished laboratory instruments and technical services. The add-on expands Surplus Solutions' refurbishment, resale and service capabilities—particularly in flow cytometry—and broadens its reach into academic, biotechnology and pharmaceutical end markets. Terms were not disclosed.
-
NAMSA Acquires SUAZIO
March 27, 2023
Healthcare Services
ARCHIMED-funded NAMSA has acquired SUAZIO, a Belgium-headquartered, data-driven life sciences and MedTech marketing and research consultancy. The add-on expands NAMSA's strategic consulting, market research and commercialization capabilities across medical devices and IVD markets; SUAZIO's founder reinvested proceeds and will continue to lead its consultancy services.
-
One Equity Partners to Acquire Fortaco Group from CapMan Buyout
July 8, 2022
Manufacturing
One Equity Partners has agreed to acquire Fortaco Group from funds managed by CapMan Buyout. The private equity buyer said it will support Fortaco’s development of its manufacturing and assembly offerings and pursue further international expansion across off-highway equipment and marine end markets. Closing is subject to regulatory approvals and customary conditions, expected in H2 2022.
-
MidEuropa Acquires Controlling Stake in FAMAR
October 17, 2024
Pharmaceuticals
MidEuropa has acquired a controlling stake in FAMAR, a European contract development and manufacturing organisation (CDMO), from ECM Partners and Metric Capital Partners, with current shareholders and management reinvesting alongside MidEuropa. FAMAR employs around 1,900 people across six manufacturing sites and two R&D centres in southern Europe and will use MidEuropa's backing to support further growth and capability expansion in pharmaceutical manufacturing and R&D.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.